Company Analysis Bayer Aktiengesellschaft
1. Summary
Advantages
- Price (27.5 $) is less than fair price (30.58 $)
- The stock's return over the last year (-8.82%) is higher than the sector average (-9.33%).
Disadvantages
- Dividends (0.4472%) are below the sector average (2.17%).
- Current debt level 35.59% has increased over 5 years from 33.29%.
- The company's current efficiency (ROE=-7.87%) is lower than the sector average (ROE=12.15%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Bayer Aktiengesellschaft | Healthcare | Index | |
|---|---|---|---|
| 7 days | 5.3% | -12.9% | 1.6% |
| 90 days | 14.8% | -14.6% | 4.7% |
| 1 year | -8.8% | -9.3% | 12.2% |
BAYZF vs Sector: Bayer Aktiengesellschaft has outperformed the "Healthcare" sector by 0.5079% over the past year.
BAYZF vs Market: Bayer Aktiengesellschaft has significantly underperformed the market by -21.03% over the past year.
Stable price: BAYZF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BAYZF with weekly volatility of -0.1696% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (27.5 $) is lower than the fair price (30.58 $).
Price not significantly lower than the fair price: The current price (27.5 $) is slightly lower than the fair price by 11.2%.
4.2. P/E
P/E vs Sector: The company's P/E (11.47) is lower than that of the sector as a whole (38.28).
P/E vs Market: The company's P/E (11.47) is lower than that of the market as a whole (59.99).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.5855) is lower than that of the sector as a whole (3.52).
P/BV vs Market: The company's P/BV (0.5855) is lower than that of the market as a whole (3.41).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.4026) is lower than that of the sector as a whole (3.74).
P/S vs Market: The company's P/S indicator (0.4026) is lower than that of the market as a whole (3.65).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (6.33) is lower than that of the sector as a whole (13.51).
EV/Ebitda vs Market: The company's EV/Ebitda (6.33) is lower than that of the market as a whole (40.09).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -13.27% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-13.27%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.61%).
5.4. ROE
ROE vs Sector: The company's ROE (-7.87%) is lower than that of the sector as a whole (12.15%).
ROE vs Market: The company's ROE (-7.87%) is lower than that of the market as a whole (41.13%).
5.5. ROA
ROA vs Sector: The company's ROA (-2.25%) is lower than that of the sector as a whole (6.06%).
ROA vs Market: The company's ROA (-2.25%) is lower than that of the market as a whole (29.31%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.34%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.01%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.4472% is below the average for the sector '2.17%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.4472% has been steadily paid over the past 7 years, DSI=0.71.
Weak dividend growth: The company's dividend yield 0.4472% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (47.83%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
